 | |
| Names | |
|---|---|
| IUPAC name (10αH)-5′α-Benzyl-12′-hydroxy-2′-(propan-2-yl)-9,10-dihydroergotaman-3′,6′,18-trione | |
| Systematic IUPAC name (6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-3,6-oxo-2-(propan-2-yl)-octahydro-8H-[1,3]oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.037.706 |
| UNII | |
| |
| |
| Properties | |
| C35H41N5O5 | |
| Molar mass | 611.73 g/mol |
| Pharmacology | |
| C04AE04 (WHO) | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Dihydroergocristine is anergotalkaloid. Alongsidedihydroergocornine anddihydroergocryptine, it is one of the components ofergoloid mesylates.
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information. |